SCHEMBL25966580

SCHEMBL25966580

CCOC(=O)CC(=O)c1ccc(O)c(OC)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.68
MEN1 O00255 4/20 0.67
KMT2A Q03164 4/20 0.67
ALDH1A1 P00352 3/20 0.67
KDM4E B2RXH2 2/20 0.67
ALOX5 P09917 1/20 0.60
NFKB1 P19838 1/20 0.60
STAT3 P40763 1/20 0.60
NFKB2 Q00653 1/20 0.60
RELA Q04206 1/20 0.60
POLB P06746 1/20 0.57
SLC22A6 Q4U2R8 1/20 0.57
SLC22A8 Q8TCC7 1/20 0.57
RAB9A P51151 1/20 0.57
HTT P42858 1/20 0.55
CYP1A2 P05177 1/20 0.55
HSP90AA1 P07900 1/20 0.55
HSP90AB1 P08238 1/20 0.55
BLM P54132 1/20 0.55
HDAC6 Q9UBN7 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2848397 0.88 MEN1 (0.70) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL31314527 0.88 MEN1 (0.70) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL12378894 0.87 MEN1 (0.68) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL24079508 0.85 SMPD1 (0.52) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL15657696 0.84 ALDH1A1 (0.65) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL15657764 0.84 MEN1 (0.65) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL10568457 0.84 MEN1 (0.64) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL19987556 0.83 KMT2A (0.51) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL7434555 0.83 KMT2A (0.63) HSD17B2MEN1KMT2AALDH1A1KDM4E
SCHEMBL28020424 0.82 MEN1 (0.57) HSD17B2MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478455-A Preparation method of cannabinoids 德义制药有限公司 2022-05-13 CN claimed
CN-114478456-A Preparation method of cannabinoids 德义制药有限公司 2022-05-13 CN claimed
US-20240018114-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS DEYI PHARMACEUTICAL LTD. (CN) 2024-01-18 US disclosed
EP-4223748-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS Deyi Pharmaceutical Ltd. (CN) 2023-08-09 EP disclosed
EP-4223749-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS Deyi Pharmaceutical Ltd. (CN) 2023-08-09 EP disclosed
CN-114478455-A Preparation method of cannabinoids 德义制药有限公司 2022-05-13 CN disclosed
CN-114478455-A Preparation method of cannabinoids 德义制药有限公司 2022-05-13 CN disclosed
CN-114478456-A Preparation method of cannabinoids 德义制药有限公司 2022-05-13 CN disclosed
CN-114478456-A Preparation method of cannabinoids 德义制药有限公司 2022-05-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018114-A1 PREPARATION METHOD FOR CANNFLAVIN COMPOUNDS HSPB1, HMBS, CYP8B1 HSD17B2 91/4885MEN1 1378/4885KMT2A 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.